Circ_0092012 knockdown restrains non-small cell lung cancer progression by inhibiting cell malignant phenotype and immune escape through microRNA-635/programmed death ligand 1 axis
收藏DataCite Commons2024-02-13 更新2024-08-18 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Circ_0092012_knockdown_restrains_non-small_cell_lung_cancer_progression_by_inhibiting_cell_malignant_phenotype_and_immune_escape_through_microRNA-635_programmed_death_ligand_1_axis/20101097
下载链接
链接失效反馈官方服务:
资源简介:
Circular RNAs have been reported to play roles in non-small cell lung cancer (NSCLC) progression. Herein, this work aimed to investigate the potential value of circ_0092012 in NSCLC progression. Levels of genes and proteins were detected using quantitative reverse transcription-polymerase chain reaction and Western blot, respectively. The growth, malignant phenotypes and immune escape in NSCLC were investigated. The binding between microRNA (miR)-635 and circ_0092012 or programmed death ligand 1 (PDL1) was verified. Circ_0092012 was highly expressed in NSCLC. Circ_0092012 deficiency suppressed NSCLC cell proliferation, invasion and migration, moreover, as well as was able to inhibit the apoptosis of CD8 + T cells and induce higher interferon-γ and tumor necrosis factor-α levels when co-cultured with peripheral blood mononuclear cells. Mechanistically, circ_0092012 sponged miR-635, which targeted PDL1. Further rescue experiments suggested that the anticancer effects of circ_0092012 knockdown were reversed by miR-635 inhibition. Additionally, miR-635 re-expression suppressed NSCLC cell malignant phenotypes mentioned above and immune escape, which were attenuated by PDL1 overexpression. Moreover, circ_0092012 deletion retarded NSCLC growth <i>in vivo</i>. In all, circ_0092012 knockdown suppressed NSCLC cell oncogenic phenotypes and immune escape by miR-635/PDL1 axis.
已有研究表明,环状RNA(circular RNAs)参与非小细胞肺癌(non-small cell lung cancer, NSCLC)的发生发展。本研究旨在探讨circ_0092012在非小细胞肺癌进展中的潜在价值。分别采用定量反转录聚合酶链反应和蛋白质印迹法(Western blot)检测相关基因与蛋白的表达水平。研究了非小细胞肺癌细胞的增殖、恶性表型及免疫逃逸情况。验证了微小RNA(microRNA, miR)-635与circ_0092012或程序性死亡配体1(programmed death ligand 1, PDL1)之间的靶向结合关系。实验结果显示,circ_0092012在非小细胞肺癌中呈高表达。敲低circ_0092012可抑制非小细胞肺癌细胞的增殖、侵袭与迁移;此外,在与外周血单个核细胞(peripheral blood mononuclear cells)共培养时,其还可抑制CD8+ T细胞凋亡,并提升干扰素-γ(interferon-γ)与肿瘤坏死因子-α(tumor necrosis factor-α)的分泌水平。机制研究显示,circ_0092012可作为分子海绵吸附miR-635,而miR-635可靶向调控PDL1的表达。进一步的拯救实验(rescue experiments)结果表明,抑制miR-635可逆转敲低circ_0092012所产生的抗肿瘤效应。此外,恢复miR-635的表达可抑制前述非小细胞肺癌细胞的恶性表型与免疫逃逸,而这一效应可被PDL1过表达所削弱。敲低circ_0092012还可在体内抑制非小细胞肺癌的生长。综上,敲低circ_0092012可通过调控miR-635/PDL1轴,抑制非小细胞肺癌细胞的致瘤表型与免疫逃逸。
提供机构:
Taylor & Francis
创建时间:
2022-06-20



